西隴科學(002584.SZ):擬續聘中興財光華會計師事務所
格隆匯12月7日丨西隴科學(002584.SZ)公佈,中興財光華會計師事務所(特殊普通合夥)(簡稱“中興財光華事務所”)具有從事證券、期貨相關業務資格,具有上市公司審計工作經驗與能力,在擔任公司2020年度審計機構期間,能夠遵循《中國註冊會計師獨立審計準則》等相關規定,勤勉盡職,堅持獨立、客觀、公正的審計準則,公允、合理地發表審計意見,較好地完成了各項審計工作,切實履行了審計機構職責。
為了保持審計工作的連續性和穩定性,公司擬續聘中興財光華事務所為公司2021年度審計機構,同時公司董事會提請股東大會授權公司管理層簽署相關協議,並根據行業市場情況和公司審計工作的實際情況決定其審計費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.